![Peter Weiler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Weiler
Direttore Finanziario/CFO presso
EDESA BIOTECH, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Peter J.
Weiler is President at Exzell Pharma, Inc. since 2018.
Mr. Weiler is Chief Financial Officer at Edesa Biotech, Inc. starting in 2025.
Formerly, Mr. Weiler was Senior Director-Analysis & Research at DRI Healthcare.
Mr. Weiler was Vice President-Business Development at BioSyent, Inc. from 2017 to 2018.
Mr. Weiler was Vice President-Business Development at Cipher Pharmaceuticals, Inc. from 2008 to 2017.
Education includes graduate studies at the University of Western Ontario and an MBA from Richard Ivey School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EDESA BIOTECH, INC. -.--% | 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Peter Weiler
| Società | Posizione | Inizio |
|---|---|---|
| EDESA BIOTECH, INC. | Direttore Finanziario/CFO | 01/05/2025 |
Exzell Pharma, Inc.
 Exzell Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells OTC and prescription pharmaceutical products | Presidente | 01/08/2018 |
Precedenti posizioni note di Peter Weiler
| Società | Posizione | Fine |
|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 01/09/2018 |
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/05/2017 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Corporate Officer/Principal | - |
Formazione di Peter Weiler
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
29
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
BioSyent, Inc.
 BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Exzell Pharma, Inc.
Exzell Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells OTC and prescription pharmaceutical products | Health Technology |
